1/ Yes! @NutritionMadeS3 -- please stay with this, it's important.

This goes back to what we were talking about last summer and why I keep drawing the distinction...

In fact, if you (and everyone else reading) would care to indulge me -- I'll unpack further...
2/ Let's definitely grant for a moment that ApoB containing lipoproteins (which we'll call ApoB-Lp) are participants in the process of ASCVD.

Can we likewise consider there are disease states (whether genetic or acquired) that result in both changes in serum ApoB-Lp *and* ASCVD?
3/ Monogenetic FH is certainly one I'd Put on the table.

In particular, a likewise constituent participant in the process of ASCVD are macrophages. Macrophages are nucleated immune cells and can thus suffer the same dysfunctional lipid metabolism we see with hepatocytes of MoFH.
4/ Please take a moment to read this study, @NutritionMadeS3 -- pubmed.ncbi.nlm.nih.gov/27680891/

I promise you'll find it quite interesting in this very context.
5/ Naturally, this begs the very important question with regard to higher ApoB-Lp where *not* due to a dysfunction in lipid metabolism (obviously, this is why we're so interested in LMHRs).

But are there others who have increased ApoB/LDL without dysfunctional lipid metabolism?
6/ Actually, there are a at least a couple dozen. But one that has had some decent study in particular is Glycogen Storage Disease (GSD). And we're especially interested in this disease given it somewhat simulates both fasting and keto (which deplete hepatic glycogen stores)...
7/ I went down a rabbit hole on GSD1a for a long time given it would have been a great analog to look at in this context. Do they have higher atherosclerosis? As it turns out -- not really...
8/ This was another interesting one as well...
9/
10/ Anyway, I bring this up because I'm counting on you, @NutritionMadeS3 to remain curious about this. It's certainly possible the ApoB exposure (per lipid hypothesis) will simply be further confirmed through our research with LMHRs (and if so, we need to know soon!)...
11/ But if not -- if there's more to the story as we suspect, you're one of the people I'm counting on to be interested in following the data where it takes us. ;)
#science

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dave Feldman 🇺🇦

Dave Feldman 🇺🇦 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @realDaveFeldman

Feb 27
🎙An absolute *must listen*!!! 🎙

1/ This podcast episode via @HCTriage, the third in a series on #ScienceTransparency, the #ReproducibilityCrisis and how we got here is easily one of the richest, and most articulated explanations I’ve heard yet podcasts.google.com/feed/aHR0cDovL…
2/ Again, an incredible triumph in science communication by @crashcoursestan @olsenvideo @DrTiff_Phd among others.

👏 👏 👏
3/
@BrianNosek:
“The big challenge as we see it is that the values that we have for how we think science should operate are not aligned with the culture, the incentives, and the policy landscape for driving how science does operate.”
Read 8 tweets
Feb 23
1/ My thoughts on being a good #Moderator

First and foremost, your top goal is to service the debate, not your own opinions.

The best moderators are those who give no clue as to where they stand on the subject because it's their express duty to leave that to participants...
2/ All your interjections in the debate should come as no surprise to anyone -- especially the participants.

In other words, clearly define the rules in advance on what you'll be enforcing, and ideally, you should announce these to the audience at the beginning as well.
3/ Thus, if someone steps out of line for these agreed upon rules and you promptly enforce them, there should be no controversy as this was expected.

A "bad call" is always a problem in any sport, the losing side feels robbed, and even the winning side feels the victory tainted.
Read 7 tweets
Feb 22
Poll 1 of 4 (Please answer all four polls)

Which of these have the biggest association to heart disease?
Poll 2 of 4

What is the *second* biggest association to heart disease? (Choose a different answer from your first)
Poll 3 of 4

Which of these are the most discussed on social media in relation to heart disease?
Read 4 tweets
Feb 13
1/ I think this is a fair question to bring forward given a severe MI can associate with reduced LDL at admission and within days of the event.

But that's also why I like this study design so much -- they exclude known CAD (coronary artery disease) at baseline...
2/ For a relevant example-- this study makes direct comparisons on symptomatic ("chest pain") patients ultimately diagnosed AMI (acute myocardial infarction, aka heart attack) vs symptomatic yet diagnosed as not having had an AMI... journals.sagepub.com/doi/full/10.41…
3/ "There were significant decreases in TC, LDL and HDL levels in both STEMI and NSTEMI patients as compared to normal subjects; however, patients with chest pain did not show any significant change in these lipids."
Read 4 tweets
Feb 13
1/ #Study #MegaThread

A new study dropped with a trove of data I've long waited for around #CCTA/#CAC scans and #LDL #Cholesterol

✅ >23k studied (!)
✅ Largest sample of CCTA w/ ≥190 #LDL to date (!)
✅ Very uniform study population

Let's unpack...
jamanetwork.com/journals/jaman…
2/ First, be sure to check out this short thread from the lead author, @MaBMortensen.

2 quick notes:
a) While there'll be lots of data appreciated by LDL skepticism, @MaBMortensen maintains LDL-C is still "an important causal RF"
b) Usual epi caveats, etc
3/ Okay, so if you've followed me a while, you know just how incredibly thankful I am of studies that seek to avoid common risks of selection bias (Even if entirely unintended).

This study had the distinct advantage of categorically scooping its population directly...
Read 18 tweets
Feb 6
1/ Reminder: I realize it’s the single hardest concept to get across, but for all these years I have and continue to suggest there’s a crucial case of lipoprotein profiles as often more a reflection of disease than the independent drivers of it. (ie — from 2018 re general👇)
2/ For example, I certainly know so much more on the workings of #LEM* than when I tweeted this from 2018, but does the foundation still hold up… do I think this is more relevant or less? Definitely more!

(*Obligatory mention of @nicknorwitz here and others re coming paper!)
3/ The bottom line is that while the independent causal role of lipoproteins (whether LDLp, sdLDL, oxLDL, glLDL, etc) are well worth examining. We should likewise investigate how *both* lipid profiles and CVD can be downstream of poor lipid metabolism.
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(